Dexcom ONE+: An Easy CGM for Type 2 27 March 2025 Advertisement ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE. Read the warnings available on dexcom.com/downloadsandguides before purchasing. Consult your healthcare professional to see if this product is right for you. This product is a continuous glucose monitoring system indicated for persons with diabetes mellitus age 2 years and older where self-monitoring of blood glucose (SMBG) is indicated. What is Dexcom One+? Dexcom ONE+ is a CGM system that gives you real-time insights—with zero fingerpricks* and is designed for people living with type 2 diabetes. Track your glucose levels effortlessly and see how meals, activity, and insulin impact your numbers, so you can make informed decisions with confidence. With superior accuracy†,1 and a waterproof sensor,‡ Dexcom ONE+ fits seamlessly into your lifestyle. Ready to manage type 2 with ease? Discover Dexcom ONE+ Dexcom ONE+… Is easy to use Self-start CGM which seamlessly integrates into your daily routine. Zero fingerpricks*. Easy and intuitive, all-in-one wearable.The smallest glucose sensor in Australia§,2 (alongside Dexcom G7)30-minute warmup, fastest of any CGM on the market.||10-day sensor wear with an additional 12-hour grace period. Waterproof when swimming, showering, and exercising.‡ Has superior accuracy †,1 Our most accurate CGM system†,1 (alongside Dexcom G7), giving you the confidence to make informed treatment decisions. Accurate across all days of wear, glucose levels (2.2 to 22.2 mmol/L) and ages (2+).3-4 Dexcom CGM is the #1 researched CGM brand in the world.# Leads to better health outcomes1,5-8 Dexcom is shown to Improve your quality of life9-10 Improve HbA1c1,5-8 Reduce highs and lows 1,5-8 Increase time in range 1,5-8 Explore more here Stay on track to be your best, with Dexcom ONE+ Check out the Dexcom Follow app^ for friends and familyThe Dexcom share feature allows friends, loved ones or caretakers to follow your glucose levels, giving you a circle of support. Use Dexcom Clarity integrationThis allows you to automatically share CGM data with your healthcare professional and see simple insights. Have access to outstanding technical supportThere is a dedicated technical support team available to help empower, inform and support customers on their Dexcom journey. Join our FREE Dexcom Warrior communityAre you using a Dexcom product? Then you can become part of a strong global advocacy movement. Connect with over 200,000 people worldwide and receive exclusive news and event invites. Join now! Get your Dexcom ONE+ today! * If your glucose alerts and readings from the device do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions† Dexcom G7 and ONE+ are our most accurate CGM systems as compared to Dexcom G6‡ The Dexcom G7 and Dexcom ONE+ sensors are waterproof and may be submerged under 2.4 metres of water for up to 24 hours without failure when properly installed§ Based on published sizes of commercially available CGM systems in Australia|| Dexcom G7 and Dexcom ONE+ can complete warmup within 30 minutes, whereas other CGM brands require up to an hour or longer# clinicaltrials.gov^ Separate Follow app and internet connection required** Smart device sold separately. To view a list of compatible devices, visit dexcom.com/compatibility 1. Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-72. Dexcom, Data on File, 20243. Garg SK, et al. Diabetes Technol Ther. 2022;24(6):373-804. Laffel LM, et al. J Diabetes Sci Technol. 2023;17(4):962-75. Beck RW, et al. JAMA. 2017;317(4):371-3786. Beck RW, et al. Ann Intern Med. 2017;167(6):365-3747. Martens T, et al. JAMA. 2021;325(22):2262-22728. Laffel LM, et al. JAMA. 2020;323(23):2388-23969. Polonsky WH, et al. Diabetes Technol Ther. 2021;23(3):195-20210.Gilbert TR, et al. Diabetes Technol Ther. 2021;23(S1):S35-S39 Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom G7, Dexcom ONE+, Dexcom Share, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. MAT-7626 March 2025
Media releases 8 April 2025 New data reveals diabetes prevalence in Australia may be 35% higher New research from the University of Sydney reveals that the number of Australians living with diabetes may be up to... Continue Reading
News 3 April 2025 Public warning: Counterfeit Ozempic pens detected in Australia The Therapeutic Goods Administration (TGA) is urging the diabetes community to remain alert following the detection of counterfeit Ozempic-labelled injection... Continue Reading
News 3 April 2025 Open letter to the diabetes research community: Investing in the future of diabetes research in Australia In December 2024, we, Diabetes Australia, announced a $40 million investment commitment to diabetes research over the next decade –... Continue Reading